En bloc resection of bladder tumour: the rebirth of past through reminiscence
Por:
Teoh, JYC, D’Andrea D., Gallioli A., Yanagisawa T., MacLennan S., Nicoletti R., Fai N.C., Maffei D., Hurle R., Lusuardi L., Malavaud B., Miki J., Kramer M., Mostafid H., Enikeev D., Babjuk M., Breda A., Shariat S., Gontero P., Herrmann T.
Publicada:
16 ago 2023
Ahead of Print:
1 ago 2023
Resumen:
PurposeTo learn about the history and development of en bloc resection of bladder tumour (ERBT), and to discuss its future directions in managing bladder cancer.MethodsIn this narrative review, we summarised the history and early development of ERBT, previous attempts in overcoming the tumour size limitation, consolidative effort in standardising the ERBT procedure, emerging evidence in ERBT, evolving concepts in treating large bladder tumours, and the future directions of ERBT.ResultsSince the first report on ERBT in 1980, there has been tremendous advancement in terms of its technique, energy modalities and tumour retrieval methods. In 2020, the international consensus statement on ERBT has been developed and it serves as a standard reference for urologists to practise ERBT. Recently, high-quality evidence on ERBT has been emerging. Of note, the EB-StaR study showed that ERBT led to a reduction in 1-year recurrence rate from 38.1 to 28.5%. An individual patient data meta-analysis is currently underway, and it will be instrumental in defining the true value of ERBT in treating non-muscle-invasive bladder cancer. For large bladder tumours, modified approaches of ERBT should be accepted, as the quality of resection is more important than a mere removal of tumour in one piece. The global ERBT registry has been launched to study the value of ERBT in a real-world setting.ConclusionERBT is a promising surgical technique in treating bladder cancer and it has gained increasing interest globally. It is about time for us to embrace this technique in our clinical practice.
Filiaciones:
Teoh, JYC:
Chinese Univ Hong Kong, SH Ho Urol Ctr, Dept Surg, Hong Kong, Peoples R China
European Assoc Urol Young Acad Urologists EAU YAU, Urothelial Canc Working Grp, Amsterdam, Netherlands
D’Andrea D.:
European Assoc Urol Young Acad Urologists EAU YAU, Urothelial Canc Working Grp, Amsterdam, Netherlands
Med Univ Vienna, Comprehens Canc Ctr, Dept Urol, Vienna, Austria
Gallioli A.:
European Assoc Urol Young Acad Urologists EAU YAU, Urothelial Canc Working Grp, Amsterdam, Netherlands
Autonoma Univ Barcelona, Dept Urol, Fundacio Puigvert, Barcelona, Spain
Yanagisawa T.:
Med Univ Vienna, Comprehens Canc Ctr, Dept Urol, Vienna, Austria
Jikei Univ, Dept Urol, Sch Med, Tokyo, Japan
MacLennan S.:
Univ Aberdeen, Acad Urol Unit, Aberdeen, Scotland
Nicoletti R.:
Chinese Univ Hong Kong, SH Ho Urol Ctr, Dept Surg, Hong Kong, Peoples R China
Univ Florence, Careggi Hosp, Unit Urol Robot Surg & Renal Transplantat, Florence, Italy
Fai N.C.:
Chinese Univ Hong Kong, SH Ho Urol Ctr, Dept Surg, Hong Kong, Peoples R China
Maffei D.:
Univ Coll London Hosp NHS Fdn Trust, Dept Urol, London, England
Human Univ, Dept Biomed Sci, Milan, Italy
Hurle R.:
IRCCS Human Res Hosp, Dept Urol, Rozzano, Italy
Lusuardi L.:
Salzburg Univ Hosp, Paracelsus Med Univ, Dept Urol & Androl, A-5020 Salzburg, Austria
Malavaud B.:
Inst Univ Canc Toulouse Oncopole, Toulouse, France
Miki J.:
Jikei Univ, Dept Urol, Sch Med, Tokyo, Japan
Kramer M.:
Univ Hosp Schleswig Holstein, Dept Urol, Lubeck, Germany
Mostafid H.:
Royal Surrey Hosp, Stokes Ctr Urol, Dept Urol, Guildford, England
Enikeev D.:
Sechenov Univ, Inst Urol & Reprod Hlth, Moscow, Russia
Babjuk M.:
Med Univ Vienna, Comprehens Canc Ctr, Dept Urol, Vienna, Austria
Charles Univ Prague, Hosp Motol, Fac Med 2, Dept Urol, Prague, Czech Republic
Breda A.:
Autonoma Univ Barcelona, Dept Urol, Fundacio Puigvert, Barcelona, Spain
Shariat S.:
Med Univ Vienna, Comprehens Canc Ctr, Dept Urol, Vienna, Austria
Sechenov Univ, Inst Urol & Reprod Hlth, Moscow, Russia
Charles Univ Prague, Hosp Motol, Fac Med 2, Dept Urol, Prague, Czech Republic
Weill Cornell Med Coll, Dept Urol, New York, NY USA
Univ Texas Southwestern, Dept Urol, Dallas, TX USA
Al Ahliyya Amman Univ, Hourani Ctr Appl Sci Res, Amman, Jordan
Gontero P.:
Univ Torino, Dept Urol Citta Salute & Sci, Sch Med, Turin, Italy
Herrmann T.:
Kantonsspital Frauenfeld, Dept Urol, Frauenfeld, Switzerland
hybrid, All Open Access; Hybrid Gold
|